strong result support view pg organ sale
growth trajectori inflect back rang
coupl improv gm outlook
pricing/mor moder commod see scope
compress pg rel valuat discount peer
fundament momentum continu pg stock ralli
follow result strong fundament headlin robust
unround organ sale growth clear high bar substanti bull
thesi top-line inflect sustain turn busi overal
view stock reaction warrant given result check sever box
underpin ow thesi see upgrad report compel
rel valu fundament inflect posit vs peer notabl
organ result unround provid greater visibl call
organ top-line growth re-rat rang year subpar
deliveri result impress underli basi consid
yr averag growth repres pg strongest result sinc well
ii weight averag market share acceler
bp yoy vs bp bp averag declin
iii top-line momentum continu broad base organ sale
growth pg top market led growth china
global product categori furthermor pg tone around price outlook
remain construct view sequenti improv price
vs flat y-o-i declin expect build
base alreadi complet well pend action combin
moder commod inflat build product save expect
gross margin expans resum vs consecut quarterli yoy
declin base detail line-item build
price out-performance sinc ep octob vs peer average
continu see scope rel out-performance pg trade
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
ntm price-to-earnings discount hpc peer cl/chd/clx/kmb despit superior
fundament outlook averag importantli see high ep estim
achiev pg vs -lsd ep downsid peer led solid visibl
organ sale growth deliveri toward upper end pg guidanc
rang perspect high end organ sale growth guidanc
would impli slowdown averag organ sale growth
vs
tweak estim price target higher result increas
ep estim respect
driven slightli favor organ sale growth margin outlook
ep estim also incorpor gain gillett land sale
ep boost y-o-i ep growth forecast toward higher end
pg guidanc rais pt base
unchang ep estim lsd premium pg
averag ntm price-to-earnings reflect acceler growth outlook
number pg core ep on-consensu
estim top-line upsid robust organ sale growth off-set slight gm
downsid drove profit beat vs consensu line
lower tax rate minor interest flatter ep cent respect
organ sale growth unround base mse came well
ahead consensu well market expect
rang two-year averag growth also acceler vs
price improv sequenti quarter vs flat
y-o-i declin report top-line beat partial
off-set weaker expect gross margin bp consensu
gm bp y-o-i unfavor commod bp fx bp
geograph mix bp off-set cost save bp sg
sale essenti in-lin consensu driven product save
bp sale leverag bp off-set bp
reinvest bp fx net oper profit beat consensu
om bp y-o-i
ep guidanc reiter rais organ sale guidanc off-set fx
commod pg rais high end organ sale growth guidanc
bp rang vs prior all-in sale growth
flat prior includ fx headwind
unchang compani reiter core ep growth unchang
base impli higher organ growth off-set fx
higher commod billion vs billion prior
exhibit pg organ sale growth acceler yoy
deriv base case scenario
top-line rebound organ sale growth revenu upsid bp
int upsid bp us upsid pg marketing/innov focu drive
market share improv cut forecast better
expect price realiz drive margin upsid turn ep growth
valuat expand ep
go forward modestli hpc peer led improv us
result build market share momentum better price realiz
continu cost save support bp om expansion/yr drive hsd ep
growth appli multipl ep slight premium pg
us led topline/margin downsid us bear case scenario play
bp pricing/volum downsid along bp margin downsid greater
reinvest outsid us bp top-line downsid bp
margin downsid drive mute lsd ep growth valuat contract
year subpar organ top-line
growth believ strategi tweak put
place recent year begin bear
fruit acceler pg top-line growth
back rang
us improv breadth perform
confid market share momentum
sustain combin
improv price outlook greater agil
organiz chang implement
support top-line growth modestli hpc
nearli year gross margin declin
expect gm expans resum
led improv price realiz
combin sizabl cost save program
worth annual profit see scope
bp annual margin expans
turn deliveri hsd ep growth
valuat look compel rel
basi pg trade ep
discount hpc peer rel valuat
look compel consid call pg
fundament posit inflect year
under-perform vs expens hpc
risk achiev price
market share vacil currenc
exhibit bear bull top-line trend stock driver
valu
sale
sale
sale bp chang
sale
sale bp chang
prepaid expens current asset
note loan payabl
current portion long-term debt
accru liabil
reserv esop debt retir
depreci amort
chang a/l
a/p accru liabil
oper asset liabil
provid oper
flow invest activ
proce asset sale
payment acquisit
use invest activ
flow financ activit
chang short-term debt
chang long-term debt
purchas treasuri share
use financ activ
provid discontinu oper
exchang rate effect
net increas decreas
equiv beg
equiv end
